About Transmembrane protease serine 3
Transmembrane protease serine 3 (TMPRSS3) is a protein
from Homo sapiens identified by UniProt accession
P57727, 454 residues long.
MolForge cross-references it against 0 known binders and
79 disease associations.
Target properties
| Protein name | Transmembrane protease serine 3 |
| UniProt accession | P57727 |
| Gene | TMPRSS3 |
| Organism | Homo sapiens |
| Length | 454 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (79)
Diseases linked to this target (Open Targets).
- hearing loss, autosomal recessive · score 0.66
- deafness · score 0.58
- nonsyndromic genetic hearing loss · score 0.58
- Rare genetic deafness · score 0.53
- autosomal dominant nonsyndromic hearing loss · score 0.48
- Hearing impairment · score 0.48
- genetic disorder · score 0.41
- hearing loss · score 0.40
- Abnormality of the ear · score 0.27
- ear malformation · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P57727-F1 | alphafold | PREDICTED | 86.62 | — |
Amino-acid sequence (454 residues)
MGENDPPAVE APFSFRSLFG LDDLKISPVA PDADAVAAQI LSLLPLKFFP IIVIGIIALI LALAIGLGIH FDCSGKYRCR SSFKCIELIA RCDGVSDCKD GEDEYRCVRV GGQNAVLQVF TAASWKTMCS DDWKGHYANV ACAQLGFPSY VSSDNLRVSS LEGQFREEFV SIDHLLPDDK VTALHHSVYV REGCASGHVV TLQCTACGHR RGYSSRIVGG NMSLLSQWPW QASLQFQGYH LCGGSVITPL WIITAAHCVY DLYLPKSWTI QVGLVSLLDN PAPSHLVEKI VYHSKYKPKR LGNDIALMKL AGPLTFNEMI QPVCLPNSEE NFPDGKVCWT SGWGATEDGA GDASPVLNHA AVPLISNKIC NHRDVYGGII SPSMLCAGYL TGGVDSCQGD SGGPLVCQER RLWKLVGATS FGIGCAEVNK PGVYTRVTSF LDWIHEQMER DLKT
Explore Transmembrane protease serine 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets